How A Leading Journal Helped A Pharma Company Exaggerate Medication Benefits - 0 views
-
Simon Knight on 20 Dec 17How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not. What if, instead, the drug reduced those same terrible outcomes by 20%? That's probably enough benefit to interest some in the drug. Well, those statistics come from the same clinical trial, evaluating the same drug. In fact, they present the exact same results, but they simply do it in different ways.